Gastroparesis clinical trials

Explore recruiting gastroparesis clinical trials.

Recruiting gastroparesis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastroparesis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A MULTICENTER OPEN LABEL 3 MONTH SAFETY STUDY WITH TRADIPITANT IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS

Belgium, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomised, placebo-controlled, dose-finding phase IIb trial to evaluate the efficacy, safety, and tolerability of a 12-week-treatment with Naronapride in adult participants with at least moderate idiopathic or diabetic gastroparesis

Italy, Austria, Belgium, Netherlands, Germany, Poland +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 1 multi-centre, randomized, single-blind, steady-state study to evaluate pharmacokinetics, pharmacodynamics, safety and tolerability after multiple-dose administration of three different doses of naronapride in patients with moderate idiopathic or diabetic gastroparesis compared to healthy subjects

Germany, Belgium, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Efficacy of domperidone (a prokinetic agent) on time in range in digestively asymptomatic type I diabetic patients with delayed gastric emptying

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gastroparesis trials by city

Gastroparesis in Toronto Gastroparesis in Vancouver Gastroparesis in Montreal Gastroparesis in Calgary Gastroparesis in Edmonton Gastroparesis in Ottawa Gastroparesis in Winnipeg Gastroparesis in Quebec City Gastroparesis in Hamilton Gastroparesis in Kitchener Gastroparesis in London Gastroparesis in Halifax Gastroparesis in New York Gastroparesis in Los Angeles Gastroparesis in Chicago Gastroparesis in Houston

Other conditions

Asthma Long COVID Cystic fibrosis Pulmonary fibrosis Sleep apnea Chronic cough Crohn's disease Ulcerative colitis Irritable bowel syndrome Celiac disease GERD Eosinophilic esophagitis Rheumatoid arthritis Lupus Psoriatic arthritis Ankylosing spondylitis Osteoarthritis Knee osteoarthritis Osteoporosis Sjogren's syndrome Scleroderma Fibromyalgia Psoriasis Eczema (atopic dermatitis)